UK markets close in 7 hours 36 minutes

HCA Healthcare, Inc. (HCA)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
247.90+1.97 (+0.80%)
At close: 4:00PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 581.97B
Enterprise value 3117.4B
Trailing P/E 17.02
Forward P/E 116.27
PEG ratio (5-yr expected) 11.15
Price/sales (ttm)1.46
Price/book (mrq)N/A
Enterprise value/revenue 32.10
Enterprise value/EBITDA 79.69

Trading information

Stock price history

Beta (5Y monthly) 1.64
52-week change 394.20%
S&P500 52-week change 334.53%
52-week high 3254.45
52-week low 3114.38
50-day moving average 3219.11
200-day moving average 3196.31

Share statistics

Avg vol (3-month) 31.38M
Avg vol (10-day) 32.12M
Shares outstanding 5330.66M
Implied shares outstanding 6N/A
Float 257.8M
% held by insiders 121.35%
% held by institutions 169.61%
Shares short (14 Jul 2021) 43.63M
Short ratio (14 Jul 2021) 42.91
Short % of float (14 Jul 2021) 41.40%
Short % of shares outstanding (14 Jul 2021) 41.10%
Shares short (prior month 14 Jun 2021) 43.71M

Dividends & splits

Forward annual dividend rate 41.92
Forward annual dividend yield 40.78%
Trailing annual dividend rate 30.96
Trailing annual dividend yield 30.39%
5-year average dividend yield 4N/A
Payout ratio 46.58%
Dividend date 329 Sept 2021
Ex-dividend date 414 Sept 2021
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Jun 2021

Profitability

Profit margin 8.87%
Operating margin (ttm)16.69%

Management effectiveness

Return on assets (ttm)12.06%
Return on equity (ttm)484.90%

Income statement

Revenue (ttm)56.02B
Revenue per share (ttm)166.80
Quarterly revenue growth (yoy)30.40%
Gross profit (ttm)19.23B
EBITDA 12.12B
Net income avi to common (ttm)4.97B
Diluted EPS (ttm)14.56
Quarterly earnings growth (yoy)34.40%

Balance sheet

Total cash (mrq)1.12B
Total cash per share (mrq)3.37
Total debt (mrq)34.34B
Total debt/equity (mrq)1,918.38
Current ratio (mrq)1.45
Book value per share (mrq)-1.78

Cash flow statement

Operating cash flow (ttm)3.37B
Levered free cash flow (ttm)-1.01B